share_log

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

POS AM：修改注册声明表
美股SEC公告 ·  2024/10/12 04:39

Moomoo AI 已提取核心信息

Aclarion, Inc. has entered into an Equity Line Purchase Agreement with White Lion Capital LLC, which was established on October 9, 2023. Under this agreement, Aclarion has the discretion to sell up to $10 million worth of shares to White Lion, subject to specified terms and conditions. As part of the ongoing financial arrangement, Aclarion has already sold 1,800,000 shares of common stock to White Lion as of August 2024. Additionally, White Lion is covered by a Registration Statement filed on October 11, 2024, for the resale of up to 1,450,000 shares of Aclarion's common stock. The capital raised from these transactions is intended for general corporate purposes, including working capital. Aclarion, which trades under the ticker 'ACON' on the Nasdaq Capital Market, has faced compliance issues with Nasdaq's minimum bid price and stockholders' equity requirements, receiving deficiency letters. In response, Aclarion is planning a reverse stock split to meet the Bid Price Requirement and has appealed the delisting notices, actively seeking solutions to regain compliance with Nasdaq's standards.
Aclarion, Inc. has entered into an Equity Line Purchase Agreement with White Lion Capital LLC, which was established on October 9, 2023. Under this agreement, Aclarion has the discretion to sell up to $10 million worth of shares to White Lion, subject to specified terms and conditions. As part of the ongoing financial arrangement, Aclarion has already sold 1,800,000 shares of common stock to White Lion as of August 2024. Additionally, White Lion is covered by a Registration Statement filed on October 11, 2024, for the resale of up to 1,450,000 shares of Aclarion's common stock. The capital raised from these transactions is intended for general corporate purposes, including working capital. Aclarion, which trades under the ticker 'ACON' on the Nasdaq Capital Market, has faced compliance issues with Nasdaq's minimum bid price and stockholders' equity requirements, receiving deficiency letters. In response, Aclarion is planning a reverse stock split to meet the Bid Price Requirement and has appealed the delisting notices, actively seeking solutions to regain compliance with Nasdaq's standards.
Aclarion, Inc.已与White Lion Capital LLC签订了股权认购协议，该公司成立于2023年10月9日。根据该协议，Aclarion有权自行卖出总价值1000万美元的股份给White Lion，但须遵守特定条款和条件。作为持续的财务安排的一部分，截至2024年8月，Aclarion已将180万股普通股出售给White Lion。此外，White Lion在2024年10月11日申报了一份注册声明，用于再出售高达145万股Aclarion普通股。这些交易所筹集的资金将用于一般公司用途，包括营运资金。Aclarion在纳斯达克资本市场上以ACON逐笔明细交易，因纳斯达克的最低买盘价格和股东权益要求而面临合规问题，收到违约通知。作为回应，Aclarion计划进行股票逆向拆分以达到买盘价格要求，并已上诉反对摘牌通知，积极寻求解决方案以恢复符合纳斯达克的标准。
Aclarion, Inc.已与White Lion Capital LLC签订了股权认购协议，该公司成立于2023年10月9日。根据该协议，Aclarion有权自行卖出总价值1000万美元的股份给White Lion，但须遵守特定条款和条件。作为持续的财务安排的一部分，截至2024年8月，Aclarion已将180万股普通股出售给White Lion。此外，White Lion在2024年10月11日申报了一份注册声明，用于再出售高达145万股Aclarion普通股。这些交易所筹集的资金将用于一般公司用途，包括营运资金。Aclarion在纳斯达克资本市场上以ACON逐笔明细交易，因纳斯达克的最低买盘价格和股东权益要求而面临合规问题，收到违约通知。作为回应，Aclarion计划进行股票逆向拆分以达到买盘价格要求，并已上诉反对摘牌通知，积极寻求解决方案以恢复符合纳斯达克的标准。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Forian
    FORA
    -- 3.590
    Ontrak
    OTRK
    -- 1.5900
    Mangoceuticals
    MGRX
    -- 4.840
    DarioHealth
    DRIO
    -- 0.700
    VSee Health
    VSEE
    -- 1.870
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    科技巨头财报季如火如荼，英伟达压轴会表现如何？
    星期四， $亚马逊 (AMZN.US)$ 股价在公司报告第四季度调整后每股收益为1.86美元，预估为每股1.50美元，营业收入为1877.9亿，预估为1873.2亿后下跌。该公司预测第一季度的营业收入数字低于华尔街的预期，预测本季度最多为1550亿，而分析师希望为1580亿。 星 展开
    亚马逊盈利预告：猜测开盘价，获取奖励！